tiprankstipranks
Trending News
More News >
BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO
Advertisement

BridgeBio Pharma (BBIO) Revenue

Compare
1,427 Followers

BridgeBio Pharma Revenue

BridgeBio Pharma had a revenue of 120.70M in the quarter ending Sep 30, 2025, with 9.17%. This bring the company's revenue in the last twelve months to 353.78M, Decreased 50.03%. In the fiscal year ending Dec 31, 2024, BridgeBio Pharma had annual revenue of 221.90M with 2285.27% growth.
Revenue (ttm)
353.78M
Revenue Growth
62.46%
P/S Ratio
62.54
Revenue/Employee
$306,072
Employees
725
Market Cap
$13.88B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
221.90M212.60M+2,385.27%
Dec 31, 2023
9.30M-68.34M+11.98%
Dec 31, 2022
77.65M7.93M+111.38%
Dec 31, 2021
69.72M61.47M+845.14%
Dec 31, 2020
8.25M-32.31M+20.34%
Dec 31, 2019
40.56M-4,056,000,000.00%
Dec 31, 2018
Dec 31, 2017
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis